NCT04343547View on ClinicalTrials.gov

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Healthy
Interventions
DRUG

DWP16001

Tablets, Oral, once daily single dose

DRUG

DWC202001+DWC202002

Tablets, Oral, multiple doses of DWC202001 and DWC202002 in combination

DRUG

DWP16001+DWC202001+DWC202002

Tablets, Oral, DWP16001 , DWC202001 and DWC202002 in combination

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT04343547 - Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With DWC202001 and DWC202002 in Healthy Male Adults | Biotech Hunter | Biotech Hunter